CUBE Tech Fair welcomes spectacular speakers

CUBE10 - 12 May 2017, Berlin, Germany.
CUBE Tech Fair welcomes Brigitte Zypries, Germany's Federal Minister for Economic Affairs and Energy. CUBE is inspired by her work at the Ministry of Economics, in which she places a strong emphasis on advancing the Industry 4.0. She supports startups as well as SMBs (small & medium-sized businesses), where she promotes various financial instruments and network opportunities offered by the BMWi.

More Speakers

Samantha Payne

Founder of Open Bionics
Co-Founder of Open Bionics; an award-winning startup developing low-cost bionic hands that look and feel good, for amputees or those born without a hand. Now part of the Disney Accelerator, powered by Techstars. Samantha, recently named as one of the top 25 women in robotics you need to know about by Robohub and Marie Claire's Top Women In Tech. The startup has won multiple other awards for innovation, including being named one of the top 50 robotics businesses in the world alongside Google and Amazon.

Pablos Holman

Futurist, inventor, and notorious hacker.
He has helped create the world's smallest PC; 3D printers at Makerbot; & spaceships with Jeff Bezos. Currently, Pablos is working for Nathan Myhrvold & Bill Gates at the Intellectual Ventures Laboratory inventing solutions to the world's biggest problems.

Jonathan Yoni Ofir

CEO of LEAF
LEAF is the plug-n-plant™ system that automatically grows medical plants and food from the comfort of your home. Yoni founded LEAF in 2015 after he decided to build a growing system for his own needs and encountered overwhelming consumer demand. In September 2015 LEAF was the first ever cannabis startup to participate in Techrunch Disrupt Battlefield. LEAF was named Product Hunt 2016 Hardware Product of the Year and was featured on VICELAND's Weediquette.

Joseph Brunner

CEO of Relayr
Josef Brunner serves as relayr’s Chief Executive Officer. Josef has been instrumental in launching multiple IT and Cyber Security companies, like JouleX (2009) and Bastille Networks (2004). Before starting relayr, he completed his tenure with Cisco Systems, which began after the 2013 Cisco acquisition of JouleX, where he was Co-Founder and Chief Architect. Josef is also an active venture capitalist through his venture capital firm AFT Ventures.

World Pharma News readers can benefit from an exclusive discount - get 30% off the ticket price using our unique promo code worldpharmanewsCUBE17 when you register online here.

Hint: The faster you buy your ticket, the cheaper it is.

About CUBE
CUBE is a Berlin-based global innovation ecosystem that aims to promote, create and foster partnerships between industry players and startups in life sciences & digital health, machinery & manufacturing as well as infrastructure & connectivity. Being part of the CUBE ecosystem allows all participants to collaborate on innovative products and ideas in response to concrete industry needs.

The annual CUBE Tech Fair, our flagship event, will take place for the first time in May 2017. For further information, please visit http://tech-fair.cube-global.com.

Most Popular Now

Novartis drug Zykadia receives FDA Priority Review…

Novartis today announced that the US Food and Drug Administration (FDA) accepted the Company's supplemental New Drug Application (sNDA) for filing, and granted Priority R...

Read more

Mutual Recognition promises new framework for phar…

The United States and the European Union (EU) completed an exchange of letters to amend the Pharmaceutical Annex to the 1998 U.S.-EU Mutual Recognition Agreement. Under t...

Read more

New analysis shows Novartis Entresto improves glyc…

Novartis has announced results of a new post-hoc analysis in a subgroup of patients with reduced ejection fraction heart failure (HFrEF) and diabetes suggesting that Entr...

Read more

Drugs similar to aspirin, ibuprofen could help tre…

A potentially life-saving treatment for sepsis has been under our noses for decades in the non-steroidal anti-inflammatory drugs (NSAIDs) most people have in their medici...

Read more

Novartis' Cosentyx shows almost all psoriasis pati…

Novartis has announced a new analysis showing that moderate-to-severe psoriasis patients treated with Cosentyx® (secukinumab) rapidly regain clear or almost clear skin (P...

Read more

Scientists stimulate immune system, stop cancer gr…

Researchers at the University of Illinois at Chicago report that increasing expression of a chemical cytokine called LIGHT in mice with colon cancer activated the immune ...

Read more

Potential drug candidates halt prostate and breast…

Scientists on the Florida campus of The Scripps Research Institute (TSRI) have designed two new drug candidates to target prostate and triple negative breast cancers. The...

Read more

Johnson & Johnson completes acquisition of Abb…

Johnson & Johnson (NYSE: JNJ) has completed the acquisition of Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott. The all-cash $4.325 billion acquisition w...

Read more

New England Journal of Medicine publishes long-ter…

In 2001 the U.S. Food and Drug Administration granted priority review for imatinib mesylate, sold under the name Gleevec®*, as an oral therapy for patients with chronic m...

Read more

Bristol-Myers Squibb expands focus on precision me…

Bristol-Myers Squibb Company (NYSE: BMY) announced its equity investment and plans for a research collaboration with GRAIL Inc., a life sciences company whose mission is ...

Read more

Volkswagen's excess emissions will lead to 1,200 p…

In September 2015, the German Volkswagen Group, the world's largest car producer, admitted to having installed "defeat devices" in 11 million diesel cars sold worldwide b...

Read more

Another record year for Bayer - good progress with…

Bayer had a very successful year in 2016, both strategically and operationally. Sales of the Bayer Group increased in 2016 by 1.5 percent (Fx & portfolio adj. 3.5 percent...

Read more

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]